SEAGULL HEALTH
Your health,We care!
Tunlametinib Capsules are the world's first and only approved targeted drug for advanced melanoma with NRAS mutation that has failed anti-PD-1/PD-L1 therapy, featuring convenient oral administration, controllable safety and definite efficacy.
AuthenticGuaranteeFast DeliveryPrivacy Tunlametinib is a targeted therapeutic drug classified as a MEK inhibitor, primarily used to inhibit the growth and spread of cancer cells. Its core e···【Read More】
Update: 12 Feb,2026Source: Haiou HealthViews: 77
Tunlametinib is a targeted therapy belonging to the MEK inhibitor class, primarily used to treat specific types of cancer (e.g., melanoma). Its common···【Read More】
Update: 12 Feb,2026Source: Haiou HealthViews: 76
The number of days Turalenib can be taken per box depends on the drug specification and the prescribed dosage. Generally, if one box contains 30 table···【Read More】
Update: 12 Feb,2026Source: Haiou HealthViews: 79
Tunlametinib capsules are an oral targeted therapeutic agent for tumors harboring specific gene mutations, mainly indicated for the treatment of malig···【Read More】
Update: 12 Feb,2026Source: Haiou HealthViews: 78
Whether Tunlametinib needs to be taken long-term depends on your specific medical condition and treatment response. It is not true that you can never ···【Read More】
Update: 12 Feb,2026Source: Haiou HealthViews: 75
The onset time of tolazoline (usually referring to tolazoline hydrochloride) is related to the route of administration and individual differences. It ···【Read More】
Update: 12 Feb,2026Source: Haiou HealthViews: 71
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH
